Literature DB >> 1703360

Histopathology of human renal allograft rejection under FK 506: a comparison with cyclosporine.

A J Demetris1, B Banner, J Fung, R Shapiro, M Jordan, T E Starzl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1703360      PMCID: PMC2967759     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.

Authors:  J J Fung; S Todo; A Jain; J McCauley; M Alessiani; C Scotti; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

2.  Pathologic observations in human allograft recipients treated with FK 506.

Authors:  A J Demetris; J J Fung; S Todo; B Banner; T Zerbe; G Sysyn; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

3.  Early trials with FK 506 as primary treatment in liver transplantation.

Authors:  S Todo; J J Fung; A J Demetris; A Jain; R Venkataramanan; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

  3 in total
  11 in total

1.  A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; J J Fung; J McCauley; P Randhawa; A J Demetris; W Irish; A Jain
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

2.  The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine.

Authors:  P S Randhawa; R Shapiro; M L Jordan; T E Starzl; A J Demetris
Journal:  Am J Surg Pathol       Date:  1993-01       Impact factor: 6.394

Review 3.  Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.

Authors:  A J Demetris; N Murase; R G Lee; P Randhawa; A Zeevi; S Pham; R Duquesnoy; J J Fung; T E Starzl
Journal:  Ann Transplant       Date:  1997       Impact factor: 1.530

4.  Tacrolimus in pediatric renal transplantation.

Authors:  R Shapiro; V P Scantlebury; M L Jordan; C Vivas; H A Gritsch; D Ellis; N Gilboa; S Lombardozzi-Lane; W Irish; J J Fung; T R Hakala; R L Simmons; T E Starzl
Journal:  Transplantation       Date:  1996-12-27       Impact factor: 4.939

5.  Pediatric renal transplantation under tacrolimus-based immunosuppression.

Authors:  R Shapiro; V P Scantlebury; M L Jordan; C Vivas; D Ellis; S Lombardozzi-Lane; N Gilboa; H A Gritsch; W Irish; J McCauley; J J Fung; T R Hakala; R L Simmons; T E Starzl
Journal:  Transplantation       Date:  1999-01-27       Impact factor: 4.939

6.  Renal transplantation at the University of Pittsburgh: the impact of FK506.

Authors:  R Shapiro; M Jordan; V P Scantlebury; C Vivas; H A Gritsch; A S Rao; M Trucco; A Zeevi; A J Demetris; P Randhawa
Journal:  Clin Transpl       Date:  1994

7.  Immunosuppressant FK506 induces interleukin-6 production through the activation of transcription factor nuclear factor (NF)-kappa(B). Implications for FK506 nephropathy.

Authors:  K Muraoka; K Fujimoto; X Sun; K Yoshioka; K Shimizu; M Yagi; H Bose; I Miyazaki; K Yamamoto
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

Review 8.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

Review 9.  The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; H A Gritsch; R J Corry; F Egidi; J McCauley; D Ellis; N Gilboa
Journal:  Clin Transpl       Date:  1995

10.  A prospective randomized trial of FK506-based immunosuppression after renal transplantation.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; J J Fung; J McCauley; P Randhawa; A J Demetris; W Irish; S Mitchell
Journal:  Transplantation       Date:  1995-02-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.